Home > National Drug Code (NDC) > Lopressor HCT

Lopressor HCT - 0078-0461-05 - (metoprolol tartrate and hydrochlorothiazide)

Alphabetical Index


Drug Information of Lopressor HCT

Product NDC: 0078-0461
Proprietary Name: Lopressor HCT
Non Proprietary Name: metoprolol tartrate and hydrochlorothiazide
Active Ingredient(s): 25; 100    mg/1; mg/1 & nbsp;   metoprolol tartrate and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Lopressor HCT

Product NDC: 0078-0461
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018303
Marketing Category: NDA
Start Marketing Date: 19841201

Package Information of Lopressor HCT

Package NDC: 0078-0461-05
Package Description: 100 TABLET in 1 BOTTLE (0078-0461-05)

NDC Information of Lopressor HCT

NDC Code 0078-0461-05
Proprietary Name Lopressor HCT
Package Description 100 TABLET in 1 BOTTLE (0078-0461-05)
Product NDC 0078-0461
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name metoprolol tartrate and hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19841201
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
Strength Number 25; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Lopressor HCT


General Information